Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 891

1.

Extended follow-up of the AdVance XP male sling in the treatment of male urinary stress incontinence after 48 months: Results of a prospective and multicenter study.

Grabbert M, Mumm JN, Klehr B, Kretschmer A, Gebhartl P, Gozzi C, Homberg R, May F, Rehder P, Stief CG, Bauer RM.

Neurourol Urodyn. 2019 Jul 11. doi: 10.1002/nau.24101. [Epub ahead of print]

PMID:
31297894
2.

Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density.

Marcon J, Graser A, Horst D, Casuscelli J, Spek A, Stief CG, Reiser MF, Rübenthaler J, Buchner A, Staehler M.

Eur Radiol. 2019 Jul 5. doi: 10.1007/s00330-019-06298-2. [Epub ahead of print]

PMID:
31278580
3.

A NAV2729-sensitive mechanism promotes adrenergic smooth muscle contraction and growth of stromal cells in the human prostate.

Yu Q, Gratzke C, Wang R, Li B, Kuppermann P, Herlemann A, Tamalunas A, Wang Y, Rutz B, Ciotkowska A, Wang X, Strittmatter F, Waidelich R, Stief CG, Hennenberg M.

J Biol Chem. 2019 Jun 26. pii: jbc.RA119.007958. doi: 10.1074/jbc.RA119.007958. [Epub ahead of print]

4.

Preoperative Thrombocytosis in Patients Undergoing Radical Cystectomy for Urothelial Cancer of the Bladder: An Independent Prognostic Parameter for an Impaired Oncological Outcome.

Jokisch JF, Grimm T, Buchner A, Kretschmer A, Weinhold P, Stief CG, Karl A, Schulz GB.

Urol Int. 2019 Jun 26:1-6. doi: 10.1159/000500729. [Epub ahead of print]

PMID:
31242481
5.

Anesthesia for Open Radical Retropubic Prostatectomy: A Comparison between Combined Spinal Epidural Anesthesia and Combined General Epidural Anesthesia.

Kofler O, Prueckner S, Weninger E, Tomasi R, Karl A, Niedermayer S, Jovanovic A, Müller HH, Stief C, Zwissler B, von Dossow V.

Prostate Cancer. 2019 May 14;2019:4921620. doi: 10.1155/2019/4921620. eCollection 2019.

6.

Prognostic value and association with epithelial-mesenchymal transition and molecular subtypes of the proteoglycan biglycan in advanced bladder cancer.

Schulz GB, Grimm T, Sers C, Riemer P, Elmasry M, Kirchner T, Stief CG, Karl A, Horst D.

Urol Oncol. 2019 Jun 5. pii: S1078-1439(19)30197-8. doi: 10.1016/j.urolonc.2019.05.011. [Epub ahead of print]

PMID:
31176613
7.

[Aftercare of non-muscle invasive bladder cancer].

Schulz GB, Schlenker B, Stief CG.

Urologe A. 2019 Jun 7. doi: 10.1007/s00120-019-0956-8. [Epub ahead of print] German.

PMID:
31175377
8.

Comparative evaluation of tissue damage induced by ultrasound and impact dual-mode endoscopic lithotripsy versus conventional single-mode ultrasound lithotripsy.

Khoder W, Strittmatter F, Alghamdi A, Seitz M, Stief C, Bader MJ.

World J Urol. 2019 May 29. doi: 10.1007/s00345-019-02747-1. [Epub ahead of print]

PMID:
31144092
9.

[Management of localized prostate cancer].

Hadaschik B, Stief CG.

Urologe A. 2019 May;58(5):485. doi: 10.1007/s00120-019-0932-3. German. No abstract available.

PMID:
31073753
10.

In vitro efficacy of phytotherapeutics suggested for prevention and therapy of urinary tract infections.

Marcon J, Schubert S, Stief CG, Magistro G.

Infection. 2019 May 8. doi: 10.1007/s15010-019-01315-4. [Epub ahead of print]

PMID:
31069724
11.

Optimized management of urolithiasis by coloured stent-stone contrast using dual-energy computed tomography (DECT).

Magistro G, Bregenhorn P, Krauß B, Nörenberg D, D'Anastasi M, Graser A, Weinhold P, Strittmatter F, Stief CG, Staehler M.

BMC Urol. 2019 Apr 30;19(1):29. doi: 10.1186/s12894-019-0459-3.

12.

[Benign prostatic enlargement: symptoms, diagnostics and therapy].

Tamalunas A, Magistro G, Grimm T, Jokisch JF, Westhofen T, Schott M, Stief CG, Weinhold P.

MMW Fortschr Med. 2019 May;161(8):50-57. doi: 10.1007/s15006-019-0017-7. German. No abstract available.

PMID:
31037703
13.

[Current controversies in the treatment of localized prostate cancer].

Bischoff R, Chaloupka M, Westhofen T, Grimm T, Schlenker B, Weinhold P, Tilki D, Stief CG, Kretschmer A.

Urologe A. 2019 May;58(5):524-528. doi: 10.1007/s00120-019-0903-8. Review. German.

PMID:
30859231
14.

Midterm Health-related Quality of Life After Radical Cystectomy: A Propensity Score-matched Analysis.

Kretschmer A, Grimm T, Buchner A, Jokisch F, Ziegelmüller B, Casuscelli J, Schulz G, Stief CG, Karl A.

Eur Urol Focus. 2019 Mar 7. pii: S2405-4569(19)30052-5. doi: 10.1016/j.euf.2019.02.017. [Epub ahead of print]

PMID:
30853603
15.

[Active surveillance of prostate cancer : An update].

Chaloupka M, Westhofen T, Kretschmer A, Grimm T, Stief C, Apfelbeck M.

Urologe A. 2019 Mar;58(3):329-340. doi: 10.1007/s00120-019-0894-5. German.

PMID:
30824971
16.

New strategies for inhibition of non-adrenergic prostate smooth muscle contraction by pharmacologic intervention.

Yu Q, Gratzke C, Wang Y, Wang X, Li B, Strittmatter F, Herlemann A, Wang R, Tamalunas A, Waidelich R, Stief CG, Hennenberg M.

Prostate. 2019 May;79(7):746-756. doi: 10.1002/pros.23780. Epub 2019 Feb 27.

PMID:
30811062
17.

[Novel minimally invasive treatment options for male lower urinary tract symptom].

Magistro G, Stief CG, Gratzke C.

Urologe A. 2019 Mar;58(3):254-262. doi: 10.1007/s00120-019-0876-7. Review. German.

PMID:
30790004
18.

Adjuvant therapy in renal cell carcinoma: the perspective of urologists.

Spek A, Szabados B, Casuscelli J, Stief C, Staehler M.

Int J Clin Oncol. 2019 Jun;24(6):694-697. doi: 10.1007/s10147-019-01398-x. Epub 2019 Feb 13.

PMID:
30758764
19.

Health-related quality of life after radical cystectomy and ileal orthotopic neobladder: effect of detailed continence outcomes.

Grimm T, Grimm J, Buchner A, Schulz G, Jokisch F, Stief CG, Karl A, Kretschmer A.

World J Urol. 2019 Jan 30. doi: 10.1007/s00345-019-02643-8. [Epub ahead of print]

PMID:
30701335
20.

[Complicated urinary tract infection: not always uncomplicated].

Bischoff R, Marcon J, Stief CG, Magistro G.

MMW Fortschr Med. 2019 Jan;161(1):44-47. doi: 10.1007/s15006-019-0067-x. Review. German. No abstract available.

PMID:
30671825
21.

[Follow-up of renal cell carcinoma in a nonmetastatic stage].

Szabados B, Foller S, Schulz GB, Staehler M, Grimm MO, Stief CG, Casuscelli J.

Urologe A. 2019 Jan;58(1):65-76. doi: 10.1007/s00120-018-0823-z. German.

PMID:
30627750
22.

[Value of imaging in upper urinary tract tumors].

Schulz GB, Gresser EK, Casuscelli J, Strittmatter F, Tritschler S, Karl A, Stief CG, Nörenberg D.

Urologe A. 2019 Jan;58(1):5-13. doi: 10.1007/s00120-018-0828-7. Review. German.

PMID:
30617530
23.

Comparison of PIRADS 3 lesions with histopathological findings after MRI-fusion targeted biopsy of the prostate in a real world-setting.

Schlenker B, Apfelbeck M, Armbruster M, Chaloupka M, Stief CG, Clevert DA.

Clin Hemorheol Microcirc. 2019;71(2):165-170. doi: 10.3233/CH-189407.

PMID:
30562897
24.

Impact of 68Ga-PSMA PET/CT on the Radiotherapeutic Approach to Prostate Cancer in Comparison to CT: A Retrospective Analysis.

Schmidt-Hegemann NS, Eze C, Li M, Rogowski P, Schaefer C, Stief C, Buchner A, Zamboglou C, Fendler WP, Ganswindt U, Cyran C, Bartenstein P, Belka C, Ilhan H.

J Nucl Med. 2019 Jul;60(7):963-970. doi: 10.2967/jnumed.118.220855. Epub 2018 Dec 14.

PMID:
30552203
25.

Harnblasenkarzinom: Update für den Hausarzt.

Stief C.

MMW Fortschr Med. 2018 Dec;160(21-22):42-43. doi: 10.1007/s15006-018-1233-2. Review. German. No abstract available.

PMID:
30542862
26.

[The UroLift® system for treatment of the benign prostatic syndrome (BPS)].

Westhofen T, Magistro G, Stief C, Gratzke C.

Aktuelle Urol. 2018 Dec;49(6):515-518. doi: 10.1055/a-0759-9185. Epub 2018 Dec 6. German.

PMID:
30522162
27.

[Burning sensation during urination].

Magistro G, Marcon J, Schulz GB, Bischoff R, Stief CG.

MMW Fortschr Med. 2018 Nov;160(20):52-55. doi: 10.1007/s15006-018-1177-6. Review. German. No abstract available.

PMID:
30478556
28.

[Urology - what are the most important trends over the last decade?]

Strittmatter F, Gratzke C, Stief C.

MMW Fortschr Med. 2018 Nov;160(Suppl 3):99-102. doi: 10.1007/s15006-018-1134-4. Review. German. No abstract available.

PMID:
30421185
29.

MRI-TRUS fusion biopsy of the prostate: Quality of image fusion in a clinical setting.

Schlenker B, Apfelbeck M, Buchner A, Stief C, Clevert DA.

Clin Hemorheol Microcirc. 2018;70(4):433-440. doi: 10.3233/CH-189308.

PMID:
30347605
30.

Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis.

Fossati N, Suardi N, Gandaglia G, Bravi CA, Soligo M, Karnes RJ, Shariat S, Battaglia A, Everaerts W, Joniau S, Van Poppel H, Rajarubendra N, Gill IS, Larcher A, Mottrie A, Schmautz M, Heidenreich A, Kalz A, Osmonov D, Juenemann KP, Herlemann A, Gratzke C, Stief C, Montorsi F, Briganti A.

Eur Urol. 2019 Jan;75(1):176-183. doi: 10.1016/j.eururo.2018.09.009. Epub 2018 Oct 6.

PMID:
30301694
31.

A simple and highly efficient method for gene silencing in Escherichia coli.

Magistro G, Magistro C, Stief CG, Schubert S.

J Microbiol Methods. 2018 Nov;154:25-32. doi: 10.1016/j.mimet.2018.10.003. Epub 2018 Oct 5.

PMID:
30296471
32.

Improved prediction of nephron-sparing surgery versus radical nephrectomy by the optimized R.E.N.A.L. Score in patients undergoing surgery for renal masses.

Sterzik A, Solyanik O, Eichelberg C, Jost M, Graser A, Lausenmeyer EM, Otto W, Waidelich R, Stief CG, Burger M, May M, Brookman-May SD.

Minerva Urol Nefrol. 2019 Jun;71(3):249-257. doi: 10.23736/S0393-2249.18.03134-X. Epub 2018 Sep 24.

PMID:
30256079
33.

The increase of stage, grading, and metastases in patients undergoing radical prostatectomy during the last decade.

Beck V, Schlenker B, Herlemann A, Apfelbeck M, Buchner A, Gratzke C, Stief CG, Tritschler S.

World J Urol. 2019 Jun;37(6):1103-1109. doi: 10.1007/s00345-018-2487-0. Epub 2018 Sep 17.

PMID:
30225798
34.

Validation of a High-End Virtual Reality Simulator for Training Transurethral Resection of Bladder Tumors.

Schulz GB, Grimm T, Buchner A, Jokisch F, Casuscelli J, Kretschmer A, Mumm JN, Ziegelmüller B, Stief CG, Karl A.

J Surg Educ. 2019 Mar - Apr;76(2):568-577. doi: 10.1016/j.jsurg.2018.08.001. Epub 2018 Sep 1.

PMID:
30181038
35.

Surgical High-risk Patients With ASA ≥ 3 Undergoing Radical Cystectomy: Morbidity, Mortality, and Predictors for Major Complications in a High-volume Tertiary Center.

Schulz GB, Grimm T, Buchner A, Jokisch F, Kretschmer A, Casuscelli J, Ziegelmüller B, Stief CG, Karl A.

Clin Genitourin Cancer. 2018 Dec;16(6):e1141-e1149. doi: 10.1016/j.clgc.2018.07.022. Epub 2018 Aug 1.

PMID:
30174234
36.

Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study.

Govers TM, Hessels D, Vlaeminck-Guillem V, Schmitz-Dräger BJ, Stief CG, Martinez-Ballesteros C, Ferro M, Borque-Fernando A, Rubio-Briones J, Sedelaar JPM, van Criekinge W, Schalken JA.

Prostate Cancer Prostatic Dis. 2019 Mar;22(1):101-109. doi: 10.1038/s41391-018-0076-3. Epub 2018 Aug 20.

PMID:
30127462
37.

High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma.

Polifka I, Agaimy A, Herrmann E, Spath V, Trojan L, Stöckle M, Becker F, Ströbel P, Wülfing C, Schrader AJ, Barth P, Staehler M, Stief C, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Höfler H, Haferkamp A, Geppert CI, Stöhr C, Hartmann A; German Network Of Kidney Cancer.

Hum Pathol. 2019 Jan;83:212-223. doi: 10.1016/j.humpath.2018.08.006. Epub 2018 Aug 17.

PMID:
30121370
38.

Emphysematous pyelonephritis: Case report and literature overview.

Ziegelmüller BK, Szabados B, Spek A, Casuscelli J, Stief C, Staehler M.

Urologia. 2018 Aug;85(3):123-126. doi: 10.1177/0391560317749428. Epub 2018 Mar 26. Review.

PMID:
30117388
39.

Vaccine Development for Urinary Tract Infections: Where Do We Stand?

Magistro G, Stief CG.

Eur Urol Focus. 2019 Jan;5(1):39-41. doi: 10.1016/j.euf.2018.07.034. Epub 2018 Aug 6. Review.

PMID:
30093359
40.

[Novel minimally invasive treatment options for male lower urinary tract symptoms].

Magistro G, Westhofen T, Stief C, Gratzke C.

Aktuelle Urol. 2018 Aug;49(4):339-345. doi: 10.1055/a-0636-3798. Epub 2018 Aug 7. German.

PMID:
30086592
41.

[Pharmacological treatment of BPS].

Westhofen T, Magistro G, Stief C, Gratzke C.

Aktuelle Urol. 2018 Aug;49(4):328-333. doi: 10.1055/a-0649-0702. Epub 2018 Aug 7. German.

PMID:
30086590
42.

The Urinary Tract Microbiome: The Answer to All Our Open Questions?

Magistro G, Stief CG.

Eur Urol Focus. 2019 Jan;5(1):36-38. doi: 10.1016/j.euf.2018.06.011. Epub 2018 Jul 2. Review.

PMID:
30042043
43.

Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis.

Schmidt-Hegemann NS, Stief C, Kim TH, Eze C, Kirste S, Strouthos I, Li M, Schultze-Seemann W, Ilhan H, Fendler WP, Bartenstein P, Grosu AL, Ganswindt U, Belka C, Meyer PT, Zamboglou C.

J Nucl Med. 2018 Jul 12. pii: jnumed.118.212563. doi: 10.2967/jnumed.118.212563. [Epub ahead of print]

44.

Inhibition of Prostate Smooth Muscle Contraction by Inhibitors of Polo-Like Kinases.

Hennenberg M, Kuppermann P, Yu Q, Herlemann A, Tamalunas A, Wang Y, Rutz B, Ciotkowska A, Strittmatter F, Stief CG, Gratzke C.

Front Physiol. 2018 Jun 15;9:734. doi: 10.3389/fphys.2018.00734. eCollection 2018.

45.

[Neuroendocrine prostate cancer].

Tritschler S, Erdelkamp R, Stief C, Hentrich M.

Pathologe. 2018 Jul;39(4):333-343. doi: 10.1007/s00292-018-0453-7. German.

PMID:
29946852
46.

[Undescended testis: current pathways of diagnostics and treatment].

Stredele R, Apfelbeck M, Mainusch M, Lellig K, Karl A, Tritschler S, Stief C, Riccabona M.

MMW Fortschr Med. 2018 Jun;160(12):58-61. doi: 10.1007/s15006-018-0709-4. Review. German. No abstract available.

PMID:
29943007
47.

Is β-endorphin significant in the control of the male sexual response?

Ückert S, Becker AJ, Bannowsky A, Stief CG, Kuczyk MA.

Andrologia. 2018 Sep;50(7):e13049. doi: 10.1111/and.13049. Epub 2018 May 20.

PMID:
29781087
48.

What's New in TIND?

Marcon J, Magistro G, Stief CG, Grimm T.

Eur Urol Focus. 2018 Jan;4(1):40-42. doi: 10.1016/j.euf.2018.04.009. Epub 2018 Apr 26. Review.

PMID:
29705283
49.

[CEUS-Use in testicular pathologies].

Marcon J, Trottmann M, Stief CG, Clevert DA.

Radiologe. 2018 Jun;58(6):572-578. doi: 10.1007/s00117-018-0387-3. Review. German.

PMID:
29704012
50.

Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101.

Yu Q, Gratzke C, Wang Y, Herlemann A, Strittmatter F, Rutz B, Stief CG, Hennenberg M.

Eur J Pharmacol. 2018 Jul 15;831:9-19. doi: 10.1016/j.ejphar.2018.04.022. Epub 2018 Apr 23.

PMID:
29698717

Supplemental Content

Support Center